Correlation Between BWV and Kezar Life
Can any of the company-specific risk be diversified away by investing in both BWV and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BWV and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BWV and Kezar Life Sciences, you can compare the effects of market volatilities on BWV and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BWV with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of BWV and Kezar Life.
Diversification Opportunities for BWV and Kezar Life
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BWV and Kezar is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding BWV and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and BWV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BWV are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of BWV i.e., BWV and Kezar Life go up and down completely randomly.
Pair Corralation between BWV and Kezar Life
If you would invest 580.00 in Kezar Life Sciences on September 2, 2024 and sell it today you would earn a total of 167.00 from holding Kezar Life Sciences or generate 28.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
BWV vs. Kezar Life Sciences
Performance |
Timeline |
BWV |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kezar Life Sciences |
BWV and Kezar Life Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BWV and Kezar Life
The main advantage of trading using opposite BWV and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BWV position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.BWV vs. Virax Biolabs Group | BWV vs. Revelation Biosciences | BWV vs. Kiora Pharmaceuticals | BWV vs. Quoin Pharmaceuticals Ltd |
Kezar Life vs. Century Therapeutics | Kezar Life vs. Mineralys Therapeutics, Common | Kezar Life vs. Nkarta Inc | Kezar Life vs. Surrozen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Fundamental Analysis View fundamental data based on most recent published financial statements |